Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study (Q42617730)

3 November 2017

Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study (English)

1 reference

3 November 2017

1 reference

Loonen AJ

1

1 reference

3 November 2017

Doorschot CH

series ordinal

2

1 reference

3 November 2017

Oostelbos MC

series ordinal

3

1 reference

3 November 2017

Sitsen JM

series ordinal

4

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

European Neuropsychopharmacology

3 November 2017

1 reference

3 November 2017

10

1 reference

3 November 2017

1

1 reference

3 November 2017

51-57

1 reference

Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats

3 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Drug-Metabolizing Enzymes and Therapeutic Drug Monitoring in Psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Risperidone versus haloperidol: I. Meta-analysis of efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Interaction of Chlorpromazine and Nortriptyline in Patients with Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

The effects of perphenazine on the concentration of nortriptyline and its hydroxymetabolites in older patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Capillary gas chromatographic assay for the routine monitoring of the antidepressant mepirzepine in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

Stimulation of median, but not dorsal, raphe 5-HT1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2899%2900054-1

7 January 2021

10.1016/S0924-977X(99)00054-1

Identifiers

DOI

1 reference

3 November 2017

1 reference